Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating N-3 Fatty Acids to Prevent Neonatal Tobacco-related outcomeS

NCT04417595 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT04417595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04417595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating N-3 Fatty Acids to Prevent Neonatal Tobacco-related outcomeS
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
November 10, 2020
Completion date
November 30, 2024
Enrollment
237 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

preterm labor, tobacco use disorder